Cargando…

A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India

PURPOSE: To derive consensus statements for surgical management of proliferative diabetic retinopathy (PDR) for vitreoretinal (VR) surgeons. METHODS: Thirteen prolific VR surgeons representing all regions of India were invited to participate in a 42-point questionnaire based on the Delphi methodolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, Sabyasachi, Sindal, Manavi D, Shanmugam, P Mahesh, Bhende, Pramod, Ratra, Dhanashree, Nagpal, Manish, Narayanan, Raja, Rajendran, Anand, Saravanan, Veerappan, Kelkar, Aditya, Maiti, Aniruddha, Chakraborty, Debdulal, Dogra, Mohit, Behera, Sourabh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725119/
https://www.ncbi.nlm.nih.gov/pubmed/34708794
http://dx.doi.org/10.4103/ijo.IJO_1265_21
_version_ 1784626049517092864
author Sengupta, Sabyasachi
Sindal, Manavi D
Shanmugam, P Mahesh
Bhende, Pramod
Ratra, Dhanashree
Nagpal, Manish
Narayanan, Raja
Rajendran, Anand
Saravanan, Veerappan
Kelkar, Aditya
Maiti, Aniruddha
Chakraborty, Debdulal
Dogra, Mohit
Behera, Sourabh
author_facet Sengupta, Sabyasachi
Sindal, Manavi D
Shanmugam, P Mahesh
Bhende, Pramod
Ratra, Dhanashree
Nagpal, Manish
Narayanan, Raja
Rajendran, Anand
Saravanan, Veerappan
Kelkar, Aditya
Maiti, Aniruddha
Chakraborty, Debdulal
Dogra, Mohit
Behera, Sourabh
author_sort Sengupta, Sabyasachi
collection PubMed
description PURPOSE: To derive consensus statements for surgical management of proliferative diabetic retinopathy (PDR) for vitreoretinal (VR) surgeons. METHODS: Thirteen prolific VR surgeons representing all regions of India were invited to participate in a 42-point questionnaire based on the Delphi methodology describing various surgical scenarios commonly encountered in PDR. Consensus was derived using predefined robust analytics. Scenarios that returned a moderate consensus in round 1 were taken to round 2 as per the Delphi methodology. After considering all inputs, the final consensus criteria were developed. RESULTS: A strong consensus was derived about waiting for 4 weeks before considering vitrectomy. In treatment-naïve eyes with fresh vitreous hemorrhage (VH), the wait time was slightly shorter for extramacular tractional retinal detachment (2–4 weeks) and longer (4–6 weeks) for eyes treated previously with laser or anti-VEGF agents. The expert panel recommended using preoperative anti-VEGF only in eyes with large membranes requiring extensive dissection. For post vitrectomy VH, while a conservative approach was recommended for the first episode of VH, experts recommended immediate vitreous lavage for recurrent episodes of VH. In eyes with iris neovascularization, the panel recommended immediate anti-VEGF injection followed by early vitreous lavage in nonresponsive eyes. A strong consensus was derived for stopping antiplatelet agents before surgery, while there was only a moderate consensus for performing vitrectomy for recalcitrant macular edema unresponsive to anti-VEGF injections in the absence of traction. CONCLUSION: This study provides valuable consensus on managing the different scenarios encountered during surgical management of PDR and should help guide the VR surgeons in clinical decision-making.
format Online
Article
Text
id pubmed-8725119
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-87251192022-01-20 A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India Sengupta, Sabyasachi Sindal, Manavi D Shanmugam, P Mahesh Bhende, Pramod Ratra, Dhanashree Nagpal, Manish Narayanan, Raja Rajendran, Anand Saravanan, Veerappan Kelkar, Aditya Maiti, Aniruddha Chakraborty, Debdulal Dogra, Mohit Behera, Sourabh Indian J Ophthalmol Original Article PURPOSE: To derive consensus statements for surgical management of proliferative diabetic retinopathy (PDR) for vitreoretinal (VR) surgeons. METHODS: Thirteen prolific VR surgeons representing all regions of India were invited to participate in a 42-point questionnaire based on the Delphi methodology describing various surgical scenarios commonly encountered in PDR. Consensus was derived using predefined robust analytics. Scenarios that returned a moderate consensus in round 1 were taken to round 2 as per the Delphi methodology. After considering all inputs, the final consensus criteria were developed. RESULTS: A strong consensus was derived about waiting for 4 weeks before considering vitrectomy. In treatment-naïve eyes with fresh vitreous hemorrhage (VH), the wait time was slightly shorter for extramacular tractional retinal detachment (2–4 weeks) and longer (4–6 weeks) for eyes treated previously with laser or anti-VEGF agents. The expert panel recommended using preoperative anti-VEGF only in eyes with large membranes requiring extensive dissection. For post vitrectomy VH, while a conservative approach was recommended for the first episode of VH, experts recommended immediate vitreous lavage for recurrent episodes of VH. In eyes with iris neovascularization, the panel recommended immediate anti-VEGF injection followed by early vitreous lavage in nonresponsive eyes. A strong consensus was derived for stopping antiplatelet agents before surgery, while there was only a moderate consensus for performing vitrectomy for recalcitrant macular edema unresponsive to anti-VEGF injections in the absence of traction. CONCLUSION: This study provides valuable consensus on managing the different scenarios encountered during surgical management of PDR and should help guide the VR surgeons in clinical decision-making. Wolters Kluwer - Medknow 2021-11 2021-10-29 /pmc/articles/PMC8725119/ /pubmed/34708794 http://dx.doi.org/10.4103/ijo.IJO_1265_21 Text en Copyright: © 2021 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sengupta, Sabyasachi
Sindal, Manavi D
Shanmugam, P Mahesh
Bhende, Pramod
Ratra, Dhanashree
Nagpal, Manish
Narayanan, Raja
Rajendran, Anand
Saravanan, Veerappan
Kelkar, Aditya
Maiti, Aniruddha
Chakraborty, Debdulal
Dogra, Mohit
Behera, Sourabh
A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India
title A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India
title_full A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India
title_fullStr A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India
title_full_unstemmed A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India
title_short A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India
title_sort delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725119/
https://www.ncbi.nlm.nih.gov/pubmed/34708794
http://dx.doi.org/10.4103/ijo.IJO_1265_21
work_keys_str_mv AT senguptasabyasachi adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT sindalmanavid adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT shanmugampmahesh adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT bhendepramod adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT ratradhanashree adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT nagpalmanish adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT narayananraja adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT rajendrananand adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT saravananveerappan adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT kelkaraditya adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT maitianiruddha adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT chakrabortydebdulal adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT dogramohit adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT beherasourabh adelphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT senguptasabyasachi delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT sindalmanavid delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT shanmugampmahesh delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT bhendepramod delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT ratradhanashree delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT nagpalmanish delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT narayananraja delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT rajendrananand delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT saravananveerappan delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT kelkaraditya delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT maitianiruddha delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT chakrabortydebdulal delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT dogramohit delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia
AT beherasourabh delphimethodbasedconsensusstatementforsurgicalmanagementofproliferativediabeticretinopathyinindia